Walvax BioTech (300142) — Tangible Net Worth Ratio
Walvax BioTech (300142) has a Tangible Net Worth Ratio of 80.7% as of June 2026. This metric is calculated by deducting intangible assets (CN¥1.42 Billion) from net assets (CN¥7.33 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset growth rate of Walvax BioTech to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Walvax BioTech Tangible Net Worth Ratio (2007–2025)
This chart shows how Walvax BioTech's Tangible Net Worth Ratio has changed across 19 annual periods from 2007 to 2025. As of June 2026, the ratio stands at 80.7%, reflecting net assets of CN¥7.33 Billion with intangible assets of CN¥1.42 Billion CNY. For live market cap and overall valuation, see market value of Walvax BioTech.
Annual Tangible Net Worth Ratio for Walvax BioTech (2007–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Walvax BioTech from 2007 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Walvax BioTech capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.0% | CN¥9.81 Billion | CN¥1.37 Billion | CN¥12.07 Billion | ▼ -1.1 pp |
| 2024 | 87.1% | CN¥11.51 Billion | CN¥1.49 Billion | CN¥14.72 Billion | ▲ +0.1 pp |
| 2023 | 87.0% | CN¥11.40 Billion | CN¥1.49 Billion | CN¥15.59 Billion | ▼ 0.0 pp |
| 2022 | 87.0% | CN¥10.99 Billion | CN¥1.43 Billion | CN¥15.34 Billion | ▲ +1.4 pp |
| 2021 | 85.5% | CN¥10.00 Billion | CN¥1.45 Billion | CN¥13.67 Billion | ▲ +0.2 pp |
| 2020 | 85.3% | CN¥7.85 Billion | CN¥1.15 Billion | CN¥9.65 Billion | ▲ +3.0 pp |
| 2019 | 82.3% | CN¥5.67 Billion | CN¥1.00 Billion | CN¥7.02 Billion | ▼ -2.0 pp |
| 2018 | 84.3% | CN¥5.26 Billion | CN¥827.23 Million | CN¥7.24 Billion | ▲ +25.1 pp |
| 2017 | 59.2% | CN¥3.56 Billion | CN¥1.45 Billion | CN¥5.88 Billion | ▼ -5.0 pp |
| 2016 | 64.2% | CN¥3.52 Billion | CN¥1.26 Billion | CN¥6.32 Billion | ▲ +3.0 pp |
| 2015 | 61.2% | CN¥3.02 Billion | CN¥1.17 Billion | CN¥6.26 Billion | ▼ -6.0 pp |
| 2014 | 67.2% | CN¥3.21 Billion | CN¥1.05 Billion | CN¥5.97 Billion | ▲ +7.5 pp |
| 2013 | 59.7% | CN¥2.94 Billion | CN¥1.18 Billion | CN¥6.14 Billion | ▼ -11.6 pp |
| 2012 | 71.3% | CN¥3.17 Billion | CN¥909.24 Million | CN¥4.45 Billion | ▼ -27.0 pp |
| 2011 | 98.4% | CN¥2.71 Billion | CN¥44.51 Million | CN¥3.01 Billion | ▼ -0.2 pp |
| 2010 | 98.5% | CN¥2.55 Billion | CN¥37.44 Million | CN¥2.99 Billion | ▲ +19.0 pp |
| 2009 | 79.6% | CN¥174.69 Million | CN¥35.69 Million | CN¥386.12 Million | ▼ -4.0 pp |
| 2008 | 83.6% | CN¥98.36 Million | CN¥16.12 Million | CN¥301.90 Million | ▲ +60.9 pp |
| 2007 | 22.7% | CN¥17.66 Million | CN¥13.64 Million | CN¥217.52 Million | — |